NCT03061123View on ClinicalTrials.gov

Patient Perceptions and Physician Assessment of Benefits and Risks of Oral Anticoagulation Due to Non-valvular AF

CompletedOBSERVATIONAL
Enrollment

91

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

October 31, 2017

Study Completion Date

October 31, 2017

Conditions
Atrial FibrillationHealth Literacy
Interventions
OTHER

Questionnaire

Trial Locations (8)

8020

Hospital Barmherzige Brueder Eggenberg, Graz

Hospital Barmherzige Brueder Marschallgasse, Graz

Hospital Elisabethinen, Graz

8036

Medical University of Graz, Graz

8230

LKH Hartberg, Hartberg

8280

LKH Fürstenfeld, Fürstenfeld

8330

LKH Feldbach, Feldbach

8345

Ordination Dr. Zweiker, Straden

All Listed Sponsors
lead

Medical University of Graz

OTHER

NCT03061123 - Patient Perceptions and Physician Assessment of Benefits and Risks of Oral Anticoagulation Due to Non-valvular AF | Biotech Hunter | Biotech Hunter